1. Home
  2. CCEP vs EW Comparison

CCEP vs EW Comparison

Compare CCEP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca-Cola Europacific Partners plc

CCEP

Coca-Cola Europacific Partners plc

N/A

Current Price

$111.80

Market Cap

46.3B

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$95.53

Market Cap

52.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEP
EW
Founded
1986
1958
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Industrial Specialties
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.3B
52.3B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
CCEP
EW
Price
$111.80
$95.53
Analyst Decision
Buy
Buy
Analyst Count
13
30
Target Price
★ $109.13
$101.87
AVG Volume (30 Days)
1.6M
★ 3.7M
Earning Date
08-04-2026
11-04-2026
Dividend Yield
★ 2.07%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.07
Revenue
N/A
★ $6,067,600,000.00
Revenue This Year
$3.48
$11.43
Revenue Next Year
$3.93
$9.91
P/E Ratio
★ $20.93
$87.21
Revenue Growth
N/A
★ 11.55
52 Week Low
$84.66
$74.66
52 Week High
$116.01
$96.29

Technical Indicators

Market Signals
Indicator
CCEP
EW
Relative Strength Index (RSI) 57.32 66.76
Support Level $90.22 $82.21
Resistance Level $114.11 $96.29
Average True Range (ATR) 2.02 2.53
MACD 0.20 0.72
Stochastic Oscillator 45.03 91.77

Price Performance

Historical Comparison
CCEP
EW

About CCEP Coca-Cola Europacific Partners plc

CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: